speb/financial-data huggingface dataset:
HHS cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1065000.00
HHS income_statement (quarterly, 2025-06-30) — Depreciation Amortization Depletion Income Statement: 1065000.00
HHS cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1065000.00
HHS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 1065000.00
HHS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 7382000.00
HHS income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.05
HHS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -335000.00
HHS income_statement (quarterly, 2025-06-30) — EBIT: 183000.00
HHS income_statement (quarterly, 2025-06-30) — EBITDA: 1248000.00
HHS cash_flow (quarterly, 2025-06-30) — Effect Of Exchange Rate Changes: 72000.00
HHS balance_sheet (quarterly, 2025-06-30) — Employee Benefits: 21272000.00
HHS cash_flow (quarterly, 2025-06-30) — End Cash Position: 4757000.00
HHS cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 778000.00
HHS cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -5073000.00
HHS balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: -13279000.00
HHS income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 24983000.00
HHS balance_sheet (quarterly, 2025-06-30) — Goodwill: 295000.00
HHS balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 761000.00
HHS balance_sheet (quarterly, 2025-06-30) — Gross Accounts Receivable: 34513000.00
HHS balance_sheet (quarterly, 2025-06-30) — Gross PPE: 68458000.00
HHS income_statement (quarterly, 2025-06-30) — Gross Profit: 26231000.00
HHS cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 990000.00
HHS cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 26000.00
HHS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 22240000.00
HHS cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -225000.00
HHS balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 19004000.00
HHS balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 19004000.00
HHS cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -39000.00
HHS cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: -21000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -335000.00
HHS cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -335000.00
HHS income_statement (quarterly, 2025-06-30) — Net Interest Income: -61000.00
HHS cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -39000.00
HHS cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -39000.00
HHS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -61000.00
HHS balance_sheet (quarterly, 2025-06-30) — Net PPE: 28618000.00
HHS cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -225000.00
HHS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 21479000.00
HHS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Assets: 15126000.00
HHS balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 15126000.00
HHS balance_sheet (quarterly, 2025-06-30) — Non Current Pension And Other Postretirement Benefit Plans: 21272000.00
HHS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 1397000.00
HHS income_statement (quarterly, 2025-06-30) — Normalized Income: -214161.00
HHS cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -4850000.00
HHS cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -588000.00
HHS income_statement (quarterly, 2025-06-30) — Operating Income: 183000.00
HHS income_statement (quarterly, 2025-06-30) — Operating Revenue: 38631000.00
HHS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 7406421.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 951000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 1910000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: -13279000.00
HHS income_statement (quarterly, 2025-06-30) — Other Gand A: 5538000.00
HHS income_statement (quarterly, 2025-06-30) — Other Income Expense: -535000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 466000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 513000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 1280000.00
HHS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: -386000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Properties: 68458000.00
HHS balance_sheet (quarterly, 2025-06-30) — Other Receivables: 6214000.00
HHS balance_sheet (quarterly, 2025-06-30) — Payables: 18610000.00
HHS balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 22336000.00
HHS cash_flow (quarterly, 2025-06-30) — Pension And Employee Benefit Expense: -588000.00
HHS balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 2719000.00
HHS income_statement (quarterly, 2025-06-30) — Pretax Income: -413000.00
HHS cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -223000.00
HHS balance_sheet (quarterly, 2025-06-30) — Receivables: 41570000.00
HHS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 12400000.00
HHS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1065000.00
HHS cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -39000.00
HHS income_statement (quarterly, 2025-06-30) — Restructuring And Mergern Acquisition: 149000.00
HHS balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 813896000.00
HHS income_statement (quarterly, 2025-06-30) — Salaries And Wages: 19445000.00
HHS cash_flow (quarterly, 2025-06-30) — Sale Of PPE: -2000.00
HHS income_statement (quarterly, 2025-06-30) — Selling General And Administration: 24983000.00
HHS balance_sheet (quarterly, 2025-06-30) — Share Issued: 12221484.00
HHS income_statement (quarterly, 2025-06-30) — Special Income Charges: -149000.00
HHS cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 220000.00
HHS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 22240000.00
HHS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 21479000.00
HHS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -28161.00
HHS income_statement (quarterly, 2025-06-30) — Tax Provision: -78000.00
HHS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.19
HHS balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 938000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Assets: 95015000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 22240000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Debt: 22725000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 22240000.00
HHS income_statement (quarterly, 2025-06-30) — Total Expenses: 38448000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 72775000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 45018000.00
HHS balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 41556000.00
HHS income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 34000.00
HHS income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 61000.00
HHS income_statement (quarterly, 2025-06-30) — Total Unusual Items: -149000.00
HHS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -149000.00
HHS balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 4815063.00
HHS balance_sheet (quarterly, 2025-06-30) — Treasury Stock: 902442000.00
HHS balance_sheet (quarterly, 2025-06-30) — Working Capital: 18778000.00
HHS income_statement (quarterly, 2025-09-30) — +Operating Expense: 26749000.00
HHS income_statement (quarterly, 2025-09-30) — +Total Revenue: 39520000.00
HHS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 18103000.00
HHS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 30206000.00
HHS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -34657000.00
HHS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 109621000.00
HHS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -6000.00
HHS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 7415000.00
HHS income_statement (quarterly, 2025-09-30) — Basic EPS: -0.31
HHS cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 4757000.00
HHS cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1006000.00
HHS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 21760000.00
HHS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 12221000.00
HHS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 6510000.00
HHS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 6510000.00
HHS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -155000.00
HHS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -1006000.00
HHS cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 3196000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Account Payable: -497000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 2300000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -21000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Payable: -497000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 1803000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -15000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Receivables: 3140000.00
HHS cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 4907000.00
HHS cash_flow (quarterly, 2025-09-30) — Changes In Cash: 2035000.00
HHS balance_sheet (quarterly, 2025-09-30) — Common Stock: 12221000.00
HHS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 19880000.00
HHS cash_flow (quarterly, 2025-09-30) — Common Stock Payments: -16000.00
HHS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 11724000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 3827000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Assets: 48698000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 3520000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 3520000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 3231000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 3231000.00
HHS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 32994000.00
HHS cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -25000.00
HHS cash_flow (quarterly, 2025-09-30) — Deferred Tax: -25000.00
HHS cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1218000.00
HHS income_statement (quarterly, 2025-09-30) — Depreciation Amortization Depletion Income Statement: 1218000.00
HHS cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1218000.00
HHS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 1218000.00
HHS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 7415000.00
HHS income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.31
HHS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — EBIT: 1047000.00
HHS income_statement (quarterly, 2025-09-30) — EBITDA: 2265000.00
HHS cash_flow (quarterly, 2025-09-30) — Effect Of Exchange Rate Changes: -282000.00
HHS balance_sheet (quarterly, 2025-09-30) — Employee Benefits: 20405000.00
HHS cash_flow (quarterly, 2025-09-30) — End Cash Position: 6510000.00
HHS cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -155000.00
HHS cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 2190000.00
HHS balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: -13487000.00
HHS income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 25531000.00
HHS balance_sheet (quarterly, 2025-09-30) — Goodwill: 295000.00
HHS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 713000.00
HHS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 30212000.00
HHS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 62287000.00
HHS income_statement (quarterly, 2025-09-30) — Gross Profit: 27796000.00
HHS cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 310000.00
HHS cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 55000.00
HHS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 19880000.00
HHS cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -1006000.00
HHS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 18240000.00
HHS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 18240000.00
HHS cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -39000.00
HHS cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: -16000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2286000.00
HHS cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -2286000.00
HHS income_statement (quarterly, 2025-09-30) — Net Interest Income: -84000.00
HHS cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -39000.00
HHS cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -39000.00
HHS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -84000.00
HHS cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -100000.00
HHS balance_sheet (quarterly, 2025-09-30) — Net PPE: 27630000.00
HHS cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1006000.00
HHS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 19167000.00
HHS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 15101000.00
HHS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 15101000.00
HHS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 20405000.00
HHS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 2803000.00
HHS income_statement (quarterly, 2025-09-30) — Normalized Income: -1860980.00
HHS cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 3196000.00
HHS cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -768000.00
HHS income_statement (quarterly, 2025-09-30) — Operating Income: 1047000.00
HHS income_statement (quarterly, 2025-09-30) — Operating Revenue: 39520000.00
HHS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 7414794.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 1735000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 4313000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -13487000.00
HHS income_statement (quarterly, 2025-09-30) — Other Gand A: 5149000.00
HHS income_statement (quarterly, 2025-09-30) — Other Income Expense: -644000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 418000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 565000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 1188000.00
HHS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -106000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Properties: 62287000.00
HHS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7286000.00
HHS balance_sheet (quarterly, 2025-09-30) — Payables: 18103000.00
HHS balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 21930000.00
HHS cash_flow (quarterly, 2025-09-30) — Pension And Employee Benefit Expense: -768000.00
HHS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 2023000.00
HHS income_statement (quarterly, 2025-09-30) — Pretax Income: 319000.00
HHS cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1006000.00
HHS balance_sheet (quarterly, 2025-09-30) — Receivables: 38430000.00
HHS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 11724000.00
HHS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1218000.00
HHS cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -39000.00
HHS cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -16000.00
HHS income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 538000.00
HHS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 811610000.00
HHS income_statement (quarterly, 2025-09-30) — Salaries And Wages: 20382000.00
HHS cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 0.00
HHS income_statement (quarterly, 2025-09-30) — Selling General And Administration: 25531000.00
HHS balance_sheet (quarterly, 2025-09-30) — Share Issued: 12221484.00
HHS income_statement (quarterly, 2025-09-30) — Special Income Charges: -538000.00
HHS cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 150000.00
HHS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 19880000.00
HHS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 19167000.00
HHS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -112980.00
HHS income_statement (quarterly, 2025-09-30) — Tax Provision: 2605000.00
HHS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
HHS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 938000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Assets: 92707000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 19880000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Debt: 21760000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 19880000.00
HHS income_statement (quarterly, 2025-09-30) — Total Expenses: 38473000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 72827000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 44009000.00
HHS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 39833000.00
HHS income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 509000.00
HHS income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 84000.00
HHS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -538000.00
HHS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -538000.00
HHS balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 4806690.00
HHS balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 900085000.00
HHS balance_sheet (quarterly, 2025-09-30) — Working Capital: 15704000.00
HHS income_statement (annual, 2025-12-31) — +Operating Expense: 107504000.00
HHS income_statement (quarterly, 2025-12-31) — +Operating Expense: 28001000.00
HHS income_statement (annual, 2025-12-31) — +Total Revenue: 159570000.00
HHS income_statement (quarterly, 2025-12-31) — +Total Revenue: 39858000.00
HHS balance_sheet (annual, 2025-12-31) — Accounts Payable: 13096000.00
HHS balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 13096000.00
HHS balance_sheet (annual, 2025-12-31) — Accounts Receivable: 27841000.00
HHS balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 27841000.00
HHS balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -34616000.00
HHS balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -34616000.00
HHS balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 109558000.00
HHS balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 109558000.00
HHS balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -22000.00
HHS balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -22000.00
HHS cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
HHS income_statement (annual, 2025-12-31) — Basic Average Shares: 7393000.00
HHS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 7415000.00
HHS income_statement (annual, 2025-12-31) — Basic EPS: -0.11
HHS income_statement (quarterly, 2025-12-31) — Basic EPS: 0.30
HHS cash_flow (annual, 2025-12-31) — Beginning Cash Position: 9934000.00
HHS cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 6510000.00
HHS balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 5284000.00
HHS balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 5284000.00
HHS cash_flow (annual, 2025-12-31) — Capital Expenditure: -2757000.00
HHS cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1423000.00
HHS balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 22404000.00
HHS balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 22404000.00
HHS balance_sheet (annual, 2025-12-31) — Capital Stock: 12221000.00
HHS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 12221000.00
HHS balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 5587000.00
HHS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 5587000.00
HHS balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5587000.00
HHS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 5587000.00
HHS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 514000.00
HHS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -41000.00
HHS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -2756000.00
HHS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -1422000.00
HHS cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -1735000.00
HHS cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 737000.00
HHS cash_flow (annual, 2025-12-31) — Change In Account Payable: -3210000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 910000.00
HHS cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -728000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -1808000.00
HHS cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1533000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -1550000.00
HHS cash_flow (annual, 2025-12-31) — Change In Payable: -3210000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Payable: 910000.00
HHS cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: -3938000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -898000.00
HHS cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -1885000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -1334000.00
HHS cash_flow (annual, 2025-12-31) — Change In Receivables: 4973000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Receivables: 2602000.00
HHS cash_flow (annual, 2025-12-31) — Change In Working Capital: -2383000.00
HHS cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -1180000.00
HHS cash_flow (annual, 2025-12-31) — Changes In Cash: -3977000.00
HHS cash_flow (quarterly, 2025-12-31) — Changes In Cash: -726000.00
HHS balance_sheet (annual, 2025-12-31) — Common Stock: 12221000.00
HHS balance_sheet (quarterly, 2025-12-31) — Common Stock: 12221000.00
HHS balance_sheet (annual, 2025-12-31) — Common Stock Equity: 20526000.00
HHS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 20526000.00
HHS cash_flow (annual, 2025-12-31) — Common Stock Payments: -65000.00
HHS cash_flow (quarterly, 2025-12-31) — Common Stock Payments: 0.00
HHS balance_sheet (annual, 2025-12-31) — Construction In Progress: 1613000.00
HHS balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 1613000.00
HHS income_statement (annual, 2025-12-31) — Cost Of Revenue: 49898000.00
HHS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 11717000.00
HHS balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 8664000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 8664000.00
HHS balance_sheet (annual, 2025-12-31) — Current Assets: 46317000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Assets: 46317000.00
HHS balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 3543000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 3543000.00
HHS balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 3543000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 3543000.00
HHS balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1681000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1681000.00
HHS balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1681000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1681000.00
HHS balance_sheet (annual, 2025-12-31) — Current Liabilities: 30164000.00
HHS balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 30164000.00
HHS cash_flow (annual, 2025-12-31) — Deferred Income Tax: -928000.00
HHS cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -852000.00
HHS cash_flow (annual, 2025-12-31) — Deferred Tax: -928000.00
HHS cash_flow (quarterly, 2025-12-31) — Deferred Tax: -852000.00
HHS cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 4472000.00
HHS cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 1126000.00
HHS income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 4472000.00
HHS income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1126000.00
HHS cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 4472000.00
HHS cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 1126000.00
HHS income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 4472000.00
HHS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1126000.00
HHS income_statement (annual, 2025-12-31) — Diluted Average Shares: 7393000.00
HHS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 7415000.00
HHS income_statement (annual, 2025-12-31) — Diluted EPS: -0.11
HHS income_statement (quarterly, 2025-12-31) — Diluted EPS: 0.30
HHS income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 2202000.00
HHS income_statement (annual, 2025-12-31) — EBIT: 2168000.00
HHS income_statement (quarterly, 2025-12-31) — EBIT: 140000.00
HHS income_statement (annual, 2025-12-31) — EBITDA: 6640000.00
HHS income_statement (quarterly, 2025-12-31) — EBITDA: 1266000.00
HHS cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -370000.00
HHS cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -197000.00
HHS balance_sheet (annual, 2025-12-31) — Employee Benefits: 21101000.00
HHS balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 21101000.00
HHS cash_flow (annual, 2025-12-31) — End Cash Position: 5587000.00
HHS cash_flow (quarterly, 2025-12-31) — End Cash Position: 5587000.00
HHS cash_flow (annual, 2025-12-31) — Financing Cash Flow: 514000.00
HHS cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -41000.00
HHS cash_flow (annual, 2025-12-31) — Free Cash Flow: -4492000.00
HHS cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -686000.00
HHS balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14980000.00
HHS balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14980000.00
HHS income_statement (annual, 2025-12-31) — General And Administrative Expense: 103032000.00
HHS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 26875000.00
HHS balance_sheet (annual, 2025-12-31) — Goodwill: 295000.00
HHS balance_sheet (quarterly, 2025-12-31) — Goodwill: 295000.00
HHS balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 665000.00
HHS balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 665000.00
HHS balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 27863000.00
HHS balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 27863000.00
HHS balance_sheet (annual, 2025-12-31) — Gross PPE: 62856000.00
HHS balance_sheet (quarterly, 2025-12-31) — Gross PPE: 62856000.00
HHS income_statement (annual, 2025-12-31) — Gross Profit: 109672000.00
HHS income_statement (quarterly, 2025-12-31) — Gross Profit: 28141000.00
HHS income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
HHS cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 1779000.00
HHS cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 283000.00
HHS cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 292000.00
HHS cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 155000.00
HHS balance_sheet (annual, 2025-12-31) — Invested Capital: 20526000.00
HHS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 20526000.00
HHS cash_flow (annual, 2025-12-31) — Investing Cash Flow: -2756000.00
HHS cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1422000.00
HHS balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 18861000.00
HHS balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 18861000.00
HHS balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 18861000.00
HHS balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 18861000.00
HHS cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -159000.00
HHS cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -41000.00
HHS balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 36105000.00
HHS balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 36105000.00
HHS cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -65000.00
HHS cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
HHS income_statement (annual, 2025-12-31) — Net Income: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 2202000.00
HHS cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -811000.00
HHS cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -811000.00
HHS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 2202000.00
HHS income_statement (annual, 2025-12-31) — Net Interest Income: -248000.00
HHS income_statement (quarterly, 2025-12-31) — Net Interest Income: -50000.00
HHS cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -159000.00
HHS cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -41000.00
HHS cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -159000.00
HHS cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -41000.00
HHS income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -248000.00
HHS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -50000.00
HHS cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 738000.00
HHS cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
HHS balance_sheet (annual, 2025-12-31) — Net PPE: 28240000.00
HHS balance_sheet (quarterly, 2025-12-31) — Net PPE: 28240000.00
HHS cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -2756000.00
HHS cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1422000.00
HHS balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 19861000.00
HHS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 19861000.00
HHS balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 16040000.00
HHS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 16040000.00
HHS balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 16040000.00
HHS balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 16040000.00
HHS balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21101000.00
HHS balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 21101000.00
HHS income_statement (annual, 2025-12-31) — Normalized EBITDA: 8422000.00
HHS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 1523000.00
HHS income_statement (annual, 2025-12-31) — Normalized Income: 621728.00
HHS income_statement (quarterly, 2025-12-31) — Normalized Income: 2405030.00
HHS cash_flow (annual, 2025-12-31) — Operating Cash Flow: -1735000.00
HHS cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 737000.00
HHS cash_flow (annual, 2025-12-31) — Operating Gains Losses: -2343000.00
HHS cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -496000.00
HHS income_statement (annual, 2025-12-31) — Operating Income: 2168000.00
HHS income_statement (quarterly, 2025-12-31) — Operating Income: 140000.00
HHS income_statement (annual, 2025-12-31) — Operating Revenue: 159570000.00
HHS income_statement (quarterly, 2025-12-31) — Operating Revenue: 39858000.00
HHS balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 7414794.00
HHS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 7414794.00
HHS balance_sheet (annual, 2025-12-31) — Other Current Assets: 2046000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2046000.00
HHS balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 3180000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 3180000.00
HHS balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -14980000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -14980000.00
HHS income_statement (annual, 2025-12-31) — Other Gand A: 22209000.00
HHS income_statement (quarterly, 2025-12-31) — Other Gand A: 5678000.00
HHS income_statement (annual, 2025-12-31) — Other Income Expense: -2928000.00
HHS income_statement (quarterly, 2025-12-31) — Other Income Expense: -397000.00
HHS balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 370000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 370000.00
HHS balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 564000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 564000.00
HHS balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1174000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1174000.00
HHS income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -1146000.00
HHS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -140000.00
HHS balance_sheet (annual, 2025-12-31) — Other Properties: 19854000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Properties: 19854000.00
HHS balance_sheet (annual, 2025-12-31) — Other Receivables: 7049000.00
HHS balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7049000.00
HHS balance_sheet (annual, 2025-12-31) — Payables: 13096000.00
HHS balance_sheet (quarterly, 2025-12-31) — Payables: 13096000.00
HHS balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 21760000.00
HHS balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 21760000.00
HHS cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -2343000.00
HHS cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: -496000.00
HHS balance_sheet (annual, 2025-12-31) — Prepaid Assets: 2363000.00
HHS balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 2363000.00
HHS income_statement (annual, 2025-12-31) — Pretax Income: -1008000.00
HHS income_statement (quarterly, 2025-12-31) — Pretax Income: -307000.00
HHS balance_sheet (annual, 2025-12-31) — Properties: 0.00
HHS balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
HHS cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2757000.00
HHS cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1423000.00
HHS balance_sheet (annual, 2025-12-31) — Receivables: 36321000.00
HHS balance_sheet (quarterly, 2025-12-31) — Receivables: 36321000.00
HHS income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 49898000.00
HHS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 11717000.00
HHS income_statement (annual, 2025-12-31) — Reconciled Depreciation: 4472000.00
HHS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 1126000.00
HHS cash_flow (annual, 2025-12-31) — Repayment Of Debt: -159000.00
HHS cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -41000.00
HHS cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -65000.00
HHS cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: 0.00
HHS income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 1782000.00
HHS income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 257000.00
HHS balance_sheet (annual, 2025-12-31) — Retained Earnings: 813812000.00
HHS balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 813812000.00
HHS income_statement (annual, 2025-12-31) — Salaries And Wages: 80823000.00
HHS income_statement (quarterly, 2025-12-31) — Salaries And Wages: 21197000.00
HHS cash_flow (annual, 2025-12-31) — Sale Of PPE: 1000.00
HHS cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1000.00
HHS income_statement (annual, 2025-12-31) — Selling General And Administration: 103032000.00
HHS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 26875000.00
HHS balance_sheet (annual, 2025-12-31) — Share Issued: 12221484.00
HHS balance_sheet (quarterly, 2025-12-31) — Share Issued: 12221484.00
HHS income_statement (annual, 2025-12-31) — Special Income Charges: -1782000.00
HHS income_statement (quarterly, 2025-12-31) — Special Income Charges: -257000.00
HHS cash_flow (annual, 2025-12-31) — Stock Based Compensation: 258000.00
HHS cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: -63000.00
HHS balance_sheet (annual, 2025-12-31) — Stockholders Equity: 20526000.00
HHS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 20526000.00
HHS balance_sheet (annual, 2025-12-31) — Tangible Book Value: 19861000.00
HHS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 19861000.00
HHS income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: -349272.00
HHS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -53970.00
HHS income_statement (annual, 2025-12-31) — Tax Provision: -197000.00
HHS income_statement (quarterly, 2025-12-31) — Tax Provision: -2509000.00
HHS income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.20
HHS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
HHS balance_sheet (annual, 2025-12-31) — Taxes Receivable: 1431000.00
HHS balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 1431000.00
HHS balance_sheet (annual, 2025-12-31) — Total Assets: 91826000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Assets: 91826000.00
HHS balance_sheet (annual, 2025-12-31) — Total Capitalization: 20526000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 20526000.00
HHS balance_sheet (annual, 2025-12-31) — Total Debt: 22404000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Debt: 22404000.00
HHS balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 20526000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 20526000.00
HHS income_statement (annual, 2025-12-31) — Total Expenses: 157402000.00
HHS income_statement (quarterly, 2025-12-31) — Total Expenses: 39718000.00
HHS balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 71300000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 71300000.00
HHS balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 45509000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 45509000.00
HHS balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 41136000.00
HHS balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 41136000.00
HHS income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 386000.00
HHS income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -117000.00
HHS income_statement (annual, 2025-12-31) — Total Other Finance Cost: 248000.00
HHS income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: 50000.00
HHS income_statement (annual, 2025-12-31) — Total Unusual Items: -1782000.00
HHS income_statement (quarterly, 2025-12-31) — Total Unusual Items: -257000.00
HHS income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: -1782000.00
HHS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -257000.00
HHS balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 4806690.00
HHS balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 4806690.00
HHS balance_sheet (annual, 2025-12-31) — Treasury Stock: 900085000.00
HHS balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 900085000.00
HHS balance_sheet (annual, 2025-12-31) — Working Capital: 16153000.00
HHS balance_sheet (quarterly, 2025-12-31) — Working Capital: 16153000.00
HHS income_statement (quarterly, 2026-03-31) — +Operating Expense: 26533000.00
HHS income_statement (quarterly, 2026-03-31) — +Total Revenue: 37264000.00
HHS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 11092000.00
HHS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 26116000.00
HHS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 108216000.00
HHS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -79000.00
HHS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 7416000.00
HHS income_statement (quarterly, 2026-03-31) — Basic EPS: -0.08
HHS cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 5587000.00
HHS cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -347000.00
HHS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 22015000.00
HHS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 12221000.00
HHS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 4538000.00
HHS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4538000.00
HHS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -50000.00
HHS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -347000.00
HHS cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -575000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1781000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -47000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 1740000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Payable: -1781000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -1828000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -1207000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Receivables: 589000.00
HHS cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -706000.00
HHS cash_flow (quarterly, 2026-03-31) — Changes In Cash: -972000.00
HHS balance_sheet (quarterly, 2026-03-31) — Common Stock: 12221000.00
HHS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 20103000.00
HHS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 11339000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 9425000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Assets: 45781000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3965000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 3965000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 3421000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 3421000.00
HHS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 30726000.00
HHS cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -25000.00
HHS cash_flow (quarterly, 2026-03-31) — Deferred Tax: -25000.00
HHS cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1082000.00
HHS income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 1082000.00
HHS cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1082000.00
HHS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 1082000.00
HHS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 7416000.00
HHS income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.08
HHS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -628000.00
HHS income_statement (quarterly, 2026-03-31) — EBIT: -929000.00
HHS income_statement (quarterly, 2026-03-31) — EBITDA: 153000.00
HHS cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -77000.00
HHS balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 20486000.00
HHS cash_flow (quarterly, 2026-03-31) — End Cash Position: 4538000.00
HHS cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -50000.00
HHS cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -922000.00
HHS balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -14984000.00
HHS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 25451000.00
HHS balance_sheet (quarterly, 2026-03-31) — Goodwill: 295000.00
HHS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 617000.00
HHS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 26195000.00
HHS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 27298000.00
HHS income_statement (quarterly, 2026-03-31) — Gross Profit: 25925000.00
HHS cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 300000.00
HHS income_statement (quarterly, 2026-03-31) — Interest Expense: 69000.00